Tetratherix Ltd has released a press release.
Executed Henry Schein Agreement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Tetratherix
- TetraDerm Cohort 2
- Q1FY26 Quarterly Activities Report/Appendix 4C
- 2025 Financial Results Investor Presentation
- 2025 Financial Results Announcement
- Appendix 4E and 2025 Annual Report
Later from Tetratherix
- Quarterly Activities/Appendix 4C Cash Flow Report
- TetraDerm Cohort 1 Results
- Half Yearly Report and Accounts
- Tutelix Update
- Precision medicine franchise launch and new revenue
Follow Tetratherix into a list and get an email when it puts out news.
Follow Tetratherix